Bogdana Schmidt
( out of 176 reviews )

Bogdana Schmidt, MD, MPH

Languages spoken: English, Russian, Spanish, Ukrainian

Clinical Locations

Huntsman Cancer Institute - Cancer Hospital South

Clinic 2B, Urology
Salt Lake City
801-587-4381

Veterans Administration Medical Center

Salt Lake City

  • Bogdana Schmidt, MD, MPH, is a urologic surgeon at the University of Utah in Salt Lake City, Utah. Dr. Schmidt specializes in urologic oncology. She attended University of San Francisco, School of Medicine and stayed to complete her residency training there. She then completed a Society of Urologic Oncology fellowship at Stanford University.

    Dr. Schmidt’s clinical interests include:

    • The treatment of bladder cancer, kidney cancer, prostate cancer, testis cancer, and penile cancer.

    • Novel imaging technologies

    • Organ preservation

    • Minimally invasive/robotic urology procedures.

    Dr. Schmidt’s research interests focus on:

    • Improving patient risk stratification and optimization of surgical outcomes

    • Quality improvement in urologic oncology

    • Addressing health disparities in urologic oncology

    • The integration of artificial intelligence and advanced imaging techniques into urologic care

    Specialties

    Patient Rating

    4.9 /5
    ( out of 176 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    June 27, 2024
    HUNTSMAN CANCER CENTER

    Professional, curtious, and very informative.

    June 26, 2024
    HUNTSMAN CANCER CENTER

    Dr Schmidt has a very broad and reasonable understanding of surgical neeeds of patients. She carries out skilled surgeries, her commitment to patient care is reassuring. Due to her scope of expertise, we patients need trust and faith in care.

    June 26, 2024
    HUNTSMAN CANCER CENTER

    Dr Schmidt was excellent I was especially pleased that she wanted to visually see the site of my stoma treatment!

    May 29, 2024
    HUNTSMAN CANCER CENTER

    She answered my concerns and gave me ideas on my future treatment

    May 28, 2024
    HUNTSMAN CANCER CENTER

    Dr Schmidt was very good at skills and a clinician, look forward to my surgery on the 31st

    May 23, 2024
    HUNTSMAN CANCER CENTER

    Dr Shmidt was excellent took time and answered all of my questions

    May 22, 2024
    HUNTSMAN CANCER CENTER

    Quick. All business. Direct.

    May 15, 2024
    HUNTSMAN CANCER CENTER

    Dr. Schmidt has been a curative blessing.

    May 08, 2024
    HUNTSMAN CANCER CENTER

    Very caring. Talks with you about your care and what she may do next

    See More Patient Comments

  • Bogdana Schmidt, MD, MPH, is a urologic surgeon at the University of Utah in Salt Lake City, Utah. Dr. Schmidt specializes in urologic oncology. She attended University of San Francisco, School of Medicine and stayed to complete her residency training there. She then completed a Society of Urologic Oncology fellowship at Stanford University.

    Dr. Schmidt’s clinical interests include:

    • The treatment of bladder cancer, kidney cancer, prostate cancer, testis cancer, and penile cancer.

    • Novel imaging technologies

    • Organ preservation

    • Minimally invasive/robotic urology procedures.

    Dr. Schmidt’s research interests focus on:

    • Improving patient risk stratification and optimization of surgical outcomes

    • Quality improvement in urologic oncology

    • Addressing health disparities in urologic oncology

    • The integration of artificial intelligence and advanced imaging techniques into urologic care

    Board Certification and Academic Information

    Academic Departments Surgery -Primary
    Academic Divisions Urology

    Education history

    Fellowship Urologic Oncology - Stanford University Fellow
    Urologic Surgery - University of California, San Francisco Resident
    Internship General Surgery - University of California, San Francisco Intern
    Medicine - University of California, San Francisco School of Medicine M.D.
    Graduate Training Community Health Science - University of California, Los Angeles M.P.H.
    Physiological Science - University of California, Los Angeles B.S.

    Selected Publications

    Journal Article

    1. Sung D, Schmidt B, Tward JD (2024). The Ability of the STAR-CAP Staging System to Prognosticate the Risk of Subsequent Therapies and Metastases After Initial Treatment of M0 Prostate Cancer. Clin Genitourin Cancer. (Read full article)
    2. Hutten R, Khouri A, Parsons M, Tward A, Wilson T, Peterson J, Morrell G, Dechet C, ONeil B, Schmidt B, Kokeny K, Lloyd S, Cannon D, Tward J, Sanchez A, Johnson S (2022). The Clinical Significance of Maximum Tumor Diameter on MRI in Men Undergoing Radical Prostatectomy or Definitive Radiotherapy for Locoregional Prostate Cancer. Clin Genitourin Cancer, 20(6), e453-e459. (Read full article)
    3. Schmidt B, Velaer KN, Thomas IC, Ganesan C, Song S, Pao AC, Thong AE, Liao JC, Chertow GM, Skinner EC, Leppert JT (2022). Renal Morbidity Following Radical Cystectomy in Patients with Bladder Cancer. Eur Urol Open Sci, 35, 29-36. (Read full article)
    4. Vilson FL, Schmidt B, White L, Sorensen SJC, Ganesan C, Pao AC, Enemchukwu E, Chertow GM, Leppert JT (2021). Removing Race from eGFR calculations: Implications for Urologic Care. Urology. (Read full article)
    5. Schmidt B, Leppert JT (2021). Costs of Robotic-Assisted Radical Prostatectomy 1 Year After Surgery: Pay Now and Save Later? JAMA Netw Open, 4(3), e212548. (Read full article)
    6. Schmidt B, Bhambhvani HP, Greenberg DR, Prado K, Shafer S, Thong A, Gill H, Skinner E, Shah JB (2020). Bupivacaine local anesthetic to decrease opioid requirements after radical cystectomy: Does formulation matter? Urol Oncol. (Read full article)
    7. Schmidt B, Eapen RS, Cowan JE, Broering JM, Greene KL, Carroll PR, Cooperberg MR (2018). Practice patterns of primary EBRT with and without ADT in prostate cancer treatment. Prostate Cancer Prostatic Dis, 22(1), 117-124. (Read full article)
    8. Schmidt B, Meng MV, Hampson LA (2018). Operating Room Supply Cost Awareness: A Cross-Sectional Analysis. Urol Pract, 6(2), 73-78. (Read full article)
    9. Truesdale MD, Elmer-Dewitt M, Sandri M, Schmidt B, Metzler I, Gadzinski A, Stoller ML, Chi T (2016). Methylene Blue Injection as an Alternative to Antegrade Nephrostography to Assess Urinary Obstruction After Percutaneous Nephrolithotomy. J Endourol, 30(4), 476-82. (Read full article)
    10. Schmidt B, Copp HL (2015). Work-up of Pediatric Urinary Tract Infection. Urol Clin North Am, 42(4), 519-26. (Read full article)
    11. Kovshilovskaya B, Chi T, Miller J, Stoller ML (2016). Systemic implications of urinary stone disease. Transl Androl Urol, 1(2), 89-96. (Read full article)
    12. Weiss DA, Kovshilovskaya B, Breyer BN (2011). Gender trends of urology manuscript authors in the United States: a 35-year progression. J Urol, 187(1), 253-8. (Read full article)
    13. Call GB, Olson JM, Chen J, Villarasa N, Ngo KT, Yabroff AM, Cokus S, Pellegrini M, Bibikova E, Bui C, Cespedes A, Chan C, Chan S, Cheema AK, Chhabra A, Chitsazzadeh V, Do MT, Fang QA, Folick A, Goodstein GL, Huang CR, Hung T, Kim E, Kim W, Kim Y, Kohan E, Kuoy E, Kwak R, Lee E, Lee J, Lin H, Liu HC, Moroz T, Prasad T, Prashad SL, Patananan AN, Rangel A, Rosselli D, Sidhu S, Sitz D, Taber CE, Tan J, Topp K, Tran P, Tran QM, Unkovic M, Wells M, Wickland J, Yackle K, Yavari A, Zaretsky JM, Allen CM, Alli L, An J, Anwar A, Arevalo S, Ayoub D, Badal SS, Baghdanian A, Baghdanian AH, Baumann SA, Becerra VN, Chan HJ, Chang AE, Cheng XA, Chin M, Chong F, Crisostomo C, Datta S, Delosreyes A, Diep F, Ekanayake P, Engeln M, Evers E, Farshidi F, Fischer K, Formanes AJ, Gong J, Gupta R, Haas BE, Hahm V, Hsieh M, Hui JZ, Iao ML, Jin SD, Kim AY, Kim LS, King M, Knudsen-Robbins C, Kohanchi D, Kovshilovskaya B, Ku A, Kung RW, Landig ME, Latterman SS, Lauw SS, Lee DS, Lee JS, Lei KC, Leung LL, Lerner R, Lin JY, Lin K, Lim BC, Lui CP, Liu TQ, Luong V, Makshanoff J, Mei AC, Meza M, Mikhaeil YA, Moarefi M, Nguyen LH, Pai SS, Pandya M, Patel AR, Picard PD, Safaee MM, Salame C, Sanchez C, Sanchez N, Seifert CC, Shah A, Shilgevorkyan OH, Singh I, Soma V, Song JJ, Srivastava N, StaAna JL, Sun C, Tan D, Teruya AS, Tikia R, Tran T, Travis EG, Trinh JD, Vo D, Walsh T, Wong RS, Wu K, Wu YW, Yang NX, Yeranosian M, Yu JS, Zhou JJ, Zhu RX, Abrams A, Abramson A, Amado L, Anderson J, Bashour K, Beyer E, Bookatz A, Brewer S, Buu N, Calvillo S, Cao J, Chan A, Chan J, Chang A, Chang D, Chang Y, Chen Y, Choi J, Chou J, Dang P, Datta S, Davarifar A, Deravanesian A, Desai P, Fabrikant J, Farnad S, Fu K, Garcia E, Garrone N, Gasparyan S, Gayda P, Go S, Goffstein C, Gonzalez C, Guirguis M, Hassid R, Hermogeno B, Hong J, Hong A, Hovestreydt L, Hu C, Huff D, Jamshidian F, Jen J, Kahen K, Kao L, Kelley M, Kho T, Kim Y, Kim S, Kirkpatrick B, Langenbacher A, Laxamana S, Lee J, Lee C, Lee SY, Lee TS, Lee T, Lewis G, Lezcano S, Lin P, Luu T, Luu J, Marrs W, Marsh E, Marshall J, Min S, Minasian T, Minye H, Misra A, Morimoto M, Moshfegh Y, Murray J, Nguyen K, Nguyen C, Nodado E 2nd, ODonahue A, Onugha N, Orjiakor N, Padhiar B, Paul E, Pavel-Dinu M, Pavlenko A, Paz E, Phaklides S, Pham L, Poulose P, Powell R, Pusic A, Ramola D, Regalia K, Ribbens M, Rifai B, Saakyan M, Saarikoski P, Segura M, Shadpour F, Shemmassian A, Singh R, Singh V, Skinner E, Solomin D, Soneji K, Spivey K, Stageberg E, Stavchanskiy M, Tekchandani L, Thai L, Thiyanaratnam J, Tong M, Toor A, Tovar S, Trangsrud K, Tsang WY, Uemura M, Vollmer E, Weiss E, Wood D, Wu J, Wu S, Wu W, Xu Q, Yamauchi Y, Yarosh W, Yee L, Yen G, Banerjee U (2007). Genomewide clonal analysis of lethal mutations in the Drosophila melanogaster eye: comparison of the X chromosome and autosomes. Genetics, 177(2), 689-97. (Read full article)

    Commentary

    1. Schmidt B, Agarwal N (2021). Black Men Receiving Radiotherapy for Localized Prostate Cancer Have Improved Outcomes-Clinical Trial Access or Racial Advantage? JAMA Netw Open, 4(12), e2140692. (Read full article)

    Case Report

    1. Vilson FL, Lin SY, Schmidt B (2020). Resolution of bilateral testicular masses after viral infection. Urol Case Rep, 33, 101388. (Read full article)

    Editorial

    1. Bergman J, Schmidt B, Leppert JT (2020). Following Up on an Improperly Drawn Screening Test: The PSA Dilemma. Am J Med, 134(3), e145-e146. (Read full article)

  • News & Podcasts

    Huntsman Cancer Institute News